197 related articles for article (PubMed ID: 25229938)
1. Resistance to therapy in acute promyelocytic leukemia.
Lehmann-Che J; Bally C; de Thé H
N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
[No Abstract] [Full Text] [Related]
2. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
Zhang X; Pan J
Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
[No Abstract] [Full Text] [Related]
3. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
4. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
5. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
[No Abstract] [Full Text] [Related]
6. Chemotherapy-free treatment of acute promyelocytic leukemia.
Ravandi F
Clin Adv Hematol Oncol; 2015 Aug; 13(8):498-500. PubMed ID: 26351810
[No Abstract] [Full Text] [Related]
7. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
Young CS; Clarke KM; Mills KI
EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
[No Abstract] [Full Text] [Related]
8. APL, a model disease for cancer therapies?
de Thé H; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7136-9. PubMed ID: 11704841
[No Abstract] [Full Text] [Related]
9. Hot on the TRAIL of acute promyelocytic leukemia.
Zelent A
Nat Med; 2001 Jun; 7(6):662-4. PubMed ID: 11385499
[No Abstract] [Full Text] [Related]
10. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
Komatsu N
Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
[No Abstract] [Full Text] [Related]
11. Treatment of acute promyelocytic leukemia.
Miura Y; Suyama K; Takano T
N Engl J Med; 2013 Oct; 369(15):1471-2. PubMed ID: 24106949
[No Abstract] [Full Text] [Related]
12. Treatment of acute promyelocytic leukemia.
Lo-Coco F; Orlando SM; Platzbecker U
N Engl J Med; 2013 Oct; 369(15):1472. PubMed ID: 24106948
[No Abstract] [Full Text] [Related]
13. Resistance to arsenic therapy in acute promyelocytic leukemia.
Zhu HH; Qin YZ; Huang XJ
N Engl J Med; 2014 May; 370(19):1864-6. PubMed ID: 24806185
[No Abstract] [Full Text] [Related]
14. Targeting agents alone to cure acute promyelocytic leukemia.
Chen SJ; Chen Z
N Engl J Med; 2013 Jul; 369(2):186-7. PubMed ID: 23841735
[No Abstract] [Full Text] [Related]
15. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
Sasaki M; Sugimoto K; Isobe Y; Oshimi K
Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
[No Abstract] [Full Text] [Related]
16. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
Mikoshiba M; Ohashi K; Takei N; Okuyama Y; Maeda Y; Hiruma K; Akiyama H; Fukuhara O; Takeshita A; Sakamaki H
Int J Hematol; 2002 Jan; 75(1):104-6. PubMed ID: 11843281
[No Abstract] [Full Text] [Related]
17. Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?
Ravandi F; Kantarjian H
Lancet Oncol; 2015 Oct; 16(13):1274-5. PubMed ID: 26384240
[No Abstract] [Full Text] [Related]
18. How health-related quality-of-life outcomes in patients with acute promyelocytic leukemia can help physicians in decision making.
Koehler M; Fischer T
J Clin Oncol; 2015 Mar; 33(9):1090-1. PubMed ID: 25691667
[No Abstract] [Full Text] [Related]
19. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
Ma J
Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
[No Abstract] [Full Text] [Related]
20. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]